DFX Intelligence
Borrowers
1,057 borrower groups currently held, grade A and BWhat a borrower group isA borrower group is every spelling of one credit agreement's borrower across the BDCs that hold it (Icefall Parent, Icefall Topco and Icefall Bidco are one). Grade A and B groups are listed; a short one-word stem (grade C) is kept apart and never merged across filers. Principal is the sum of BDC pieces and is a lower bound.Principal and marks are the filers' figures at each BDC's latest quarter end, summed. Maturity is the filer's tagged date or the date written into the identifier; a BDC that tags neither leaves it unstated.
Start from
1,057 borrower groups match
| Borrower | Sponsor | BDCs | Principal held | On cost | Spread | Next maturity | First seen |
|---|---|---|---|---|---|---|---|
| AccentCare Life sciences | unattributed | 4 | at least $6.4M | 94c | n/a | Jun 20, 2028 | Dec 31, 2021 |
| Aquestive Therapeutics, Inc Life sciences | unattributed | 1 | at least $6.3M | 100c | n/a | May 12, 2031 | Sep 30, 2025 |
| MedAssets Software Intermediate Holdings, Inc Healthcare services | unattributed | 1 | at least $6.1M | 59c | n/a | Dec 15, 2028 | Dec 31, 2022 |
| C••••• H••••• a• H•••• L•• Healthcare services | Sponsor not establishedpossible: T•••• C•••••• M••••••••• L•• (a company of this name is on the sponsor's portfolio page) | 2 | at least $6.1M | 100c | n/a | Jun 30, 2028 | Dec 31, 2022 |
| C••••••••• Life sciences | Sponsor not establishedpossible: W••••••• C•••••• P••••••• L•• (a company of this name is on the sponsor's portfolio page) | 1 | at least $6.1M | 98c | n/a | Jun 30, 2029 | Mar 31, 2023 |
| N•••••••• L•• Life sciences | unattributed | 1 | at least $6.1M | 95c | n/a | May 15, 2027 | Jun 30, 2026 |
| I•••••••• H••••• P••••••••• L•• Healthcare services | unattributed | 2 | at least $6.0M | 101c | n/a | Feb 2, 2032 | Mar 31, 2026 |
| A••••••••• L•• Life sciences | Sponsor not establishedpossible: L••••• M•••••• P••••••• L•• (a company of this name is on the sponsor's portfolio page) | 1 | at least $5.9M | 100c | n/a | Oct 31, 2029 | Dec 31, 2023 |
| B••••• B••••••••• S•••••• S••••••• L•• F•••• A•••••••• Healthcare services | unattributed | 1 | at least $5.9M | 100c | n/a | Jun 21, 2029 | Jun 30, 2026 |
| O•••• Life sciences · grade B | unattributed | 1 | at least $5.8M | 101c | n/a | Jun 30, 2028 | Jun 30, 2025 |
| A•••••• H•••••• G••• Life sciences | unattributed | 2 | at least $5.8M | 99c | n/a | Nov 29, 2032 | Dec 31, 2025 |
| S•• C•••• A•• o• Life sciences | unattributed | 1 | at least $5.7M | 100c | n/a | Oct 24, 2032 | Jun 30, 2026 |
| D••••••••• I••••••••• H••••••• I••• I•• Healthcare services | unattributed | 3 | at least $5.7M | 98c | 1 pts | Mar 30, 2029 | Dec 31, 2022 |
| S••••••••• D••• B••••• B••••••••• H•••••••• L•• Healthcare services | unattributed | 1 | at least $5.6M | 101c | n/a | Jun 21, 2030 | Sep 30, 2024 |
| C••••••• P••• S•••••••• Healthcare services | unattributed | 1 | at least $5.6M | 101c | n/a | Aug 30, 2030 | Dec 31, 2024 |
| G•••••• B••••••••• I•• Life sciences | unattributed | 1 | at least $5.6M | 105c | n/a | Sep 13, 2027 | Jun 30, 2026 |
| J••• H•••••• I•• Healthcare services | unattributed | 1 | at least $5.5M | 101c | n/a | Aug 16, 2029 | Sep 30, 2024 |
| D••••• I•• Life sciences | unattributed | 3 | at least $5.5M | 100c | n/a | May 9, 2031 | Jun 30, 2024 |
| K••• O•••••••• I•• Life sciences | unattributed | 1 | at least $5.5M | 102c | n/a | Nov 1, 2027 | Dec 31, 2022 |
| R••••••••• Healthcare services | unattributed | 5 | at least $5.5M | 102c | n/a | Dec 19, 2030 | Dec 31, 2022 |
| E••• H••• H••••• S•••••••• I••••••••• L•• Education | unattributed | 3 | at least $5.4M | 94c | n/a | May 10, 2030 | Jun 30, 2024 |
| D•• T•••• L• Healthcare services | unattributed | 14 | at least $5.4M | 100c | n/a | Apr 1, 2031 | Jun 30, 2026 |
| G•••• L•••• D••••• P•••••••• L•• Life sciences | unattributed | 1 | at least $5.4M | 100c | n/a | Jun 30, 2027 | Dec 31, 2022 |
| A••••••••• C••• A•• G•••• H•••••••• I•• Healthcare services | unattributed | 1 | at least $5.1M | 69c | n/a | Aug 2, 2028 | Dec 31, 2022 |
| C••• M•••• 2• L•• Life sciences | unattributed | 5 | at least $5.1M | 99c | n/a | Oct 13, 2029 | Sep 30, 2022 |
| e•• I••••••• I•• Life sciences | unattributed | 2 | at least $5.0M | 100c | n/a | Dec 1, 2028 | Dec 31, 2025 |
| S••••• B••••••••• H••••••••• L•• Healthcare services | unattributed | 6 | at least $5.0M | 74c | n/a | Dec 31, 2029 | Sep 30, 2021 |
| G••••• A•• Life sciences | unattributed | 3 | at least $5.0M | 100c | 0 pts | Dec 13, 2032 | Dec 31, 2025 |
| V•••• B••••• I•• Life sciences | unattributed | 2 | at least $4.9M | 100c | n/a | Dec 15, 2031 | Dec 31, 2024 |
| S•••••• L•• Life sciences · grade B | unattributed | 1 | at least $4.8M | 100c | n/a | Dec 29, 2026 | Sep 30, 2023 |
| F• D•• B••••• I•• Life sciences | unattributed | 3 | at least $4.7M | 101c | n/a | Oct 11, 2030 | Dec 31, 2023 |
| K• C•••••• A••••••••• C•••••• F••••• A•••••••• Life sciences | unattributed | 1 | at least $4.7M | 101c | n/a | Dec 30, 2026 | Mar 31, 2024 |
| M••••• 5••• G••• Life sciences | unattributed | 2 | at least $4.6M | 101c | n/a | May 28, 2028 | Dec 31, 2021 |
| P••••• D••••••••• L•• Healthcare services | unattributed | 7 | at least $4.6M | 100c | n/a | Oct 20, 2029 | Dec 31, 2021 |
| C•••••• T••••••••• G••••• I•• Life sciences | unattributed | 1 | at least $4.5M | 100c | n/a | Jan 1, 2030 | Mar 31, 2026 |
| C•••• R••••••••• I• S•• L•• Life sciences | unattributed | 3 | at least $4.5M | 100c | n/a | Jan 29, 2029 | Dec 31, 2025 |
| R•••••••• Life sciences | Sponsor not establishedpossible: W••••••• H••••• I••••••••• L•• (a company of this name is on the sponsor's portfolio page) | 1 | at least $4.5M | 74c | n/a | Jul 21, 2028 | Dec 31, 2022 |
| S•••• D••••• S•••••• L•• Life sciences | unattributed | 1 | at least $4.4M | 85c | n/a | Jun 30, 2028 | Dec 31, 2022 |
| I••••••••• P••• M••••••••• M•••••• G••••• I•• Life sciences | unattributed | 1 | at least $4.3M | 96c | n/a | Dec 31, 2026 | Mar 31, 2023 |
| T••• A• S••• B•••••••• M••••••••• L•• Healthcare services | unattributed | 1 | at least $4.2M | 100c | n/a | Oct 31, 2028 | Dec 31, 2025 |
| M••••• H••••••••• S••••••••• I•• Life sciences | unattributed | 1 | at least $4.1M | 40c | n/a | Dec 15, 2026 | Dec 31, 2022 |
| T••• A•••••••• I••••••••• S••• B•••••••• M••••••••• L•• Healthcare services | unattributed | 1 | at least $4.1M | 100c | n/a | Oct 31, 2028 | Dec 31, 2025 |
| S••• P•••••• I•• Life sciences | unattributed | 9 | at least $4.1M | 100c | n/a | Sep 27, 2030 | Sep 30, 2023 |
| D••••••• V••••• M••••••••• H•••••••• I•• Healthcare services | Sponsor not establishedpossible: B•••••• I••••••••• A••••••• (a company of this name is on the sponsor's portfolio page) | 1 | at least $4.1M | 39c | n/a | Dec 31, 2026 | Dec 31, 2022 |
| Q••••••••• C••••••••• Life sciences | unattributed | 5 | at least $4.0M | 99c | n/a | Aug 20, 2032 | Sep 30, 2025 |
| M•••• • A••••••• Life sciences | unattributed | 1 | at least $4.0M | 102c | n/a | May 3, 2029 | Jun 30, 2023 |
| P••••••• O••• H••••• Life sciences | Sponsor not establishedpossible: I••••••• C•••••• P•••••••• L•• (a company of this name is on the sponsor's portfolio page) | 1 | at least $4.0M | 101c | n/a | Nov 16, 2028 | Dec 31, 2023 |
| I•••••••• F•••• S•• r•• Healthcare services | Sponsor not establishedpossible: S•••• C•••••• M••••••••• L•• (a company of this name is on the sponsor's portfolio page) | 2 | at least $3.9M | 101c | n/a | Apr 18, 2031 | Mar 31, 2024 |
| i•••• P••••••••• P•• L•••••• Life sciences | Sponsor not establishedpossible: P•••••• E••••• P••••••• P•• L•••••• (a company of this name is on the sponsor's portfolio page) | 1 | at least $3.9M | 100c | n/a | Nov 1, 2031 | Dec 31, 2022 |
| C•••• H••••••••• C••• B••••••• L•• Life sciences | unattributed | 2 | at least $3.9M | 100c | n/a | Apr 29, 2033 | Sep 30, 2025 |
The borrower, lender and sponsor names past the first 3 rows are hidden. Open a row to reveal that record with a free account (5 a month), or get Private Credit Intelligence at $249 a month for every name. Every figure, date and source is public either way.